Table of Contents
What changed
- Revenue fell from NZ$33.8m to NZ$2.7m (-92.1%), essentially running off the remaining interest and fee income base.
- The loss before tax narrowed to NZ$101.2m from NZ$215.7m (+53.1%). With income tax nil in both periods, NPAT equals PBT, so there is no tax distortion to strip out.
- Operating cash flow swung to a NZ$147.1m outflow, from a NZ$331.3m inflow in HY22 — a NZ$478.3m reversal.
- Despite the operating outflow, period-end cash rose to NZ$1.0bn from NZ$152.4m, while gross borrowings fell to NZ$930.3m from NZ$1.44bn. Net debt of NZ$1.28bn turned into net cash of roughly NZ$71.0m.
- Total equity moved from a NZ$76.6m deficit to NZ$129.8m positive. No dividend is proposed.
What matters
- The balance sheet has been recapitalised. Borrowings down NZ$505.6m and cash up NZ$848.8m is not an operating outcome; it is consistent with the capital raise and RTO process flagged in the HY22 excerpts. The shift from negative equity to NZ$129.8m of positive equity is the most substantive change in the release.
- The operating business has effectively stopped. Revenue of NZ$2.7m against a NZ$101.2m loss, and a NZ$147.1m operating cash outflow, indicate continued run-off of the legacy book rather than a going-concern trading entity. The "improvement" in reported loss is relative; the P&L remains deeply negative on a near-nil revenue base.
- Cash conversion deteriorated sharply. Operating cash flow is now a NZ$147.1m drain against a NZ$101.2m accounting loss, so cash is leaving the business faster than the P&L loss suggests.
Expectations
No forward guidance, forward-work disclosure or quantitative target was provided in the supplied release. HY22 represented 86.1% of FY22 revenue and 56.4% of FY22 NPAT, so the prior year was not second-half weighted; against that shape, HY23 revenue annualises to roughly NZ$5.3m versus FY22's NZ$39.2m, a further step-down. The release does support the conclusion that a reverse-takeover/recapitalisation path has progressed (cash built, debt reduced, equity restored); it does not support any view on what future earnings power looks like, because no operating target or acquisition economics are disclosed.
Quality of result
Low, viewed as an operating read. The headline "improvement" in PBT is mechanical — a smaller loss on a smaller revenue base, with no tax, capex, EBITDA or segment disclosure to test durability. The balance-sheet improvement is real but structural rather than operational: it reflects refinancing and capital inflows rather than cash generated by trading. The NZ$478.3m swing in operating cash flow against only a NZ$114.5m narrowing of the loss confirms that reported profit and cash have decoupled, and that the prior HY22 operating inflow was itself driven by balance-sheet items rather than trading margin.
Unresolved
- What is the nature and status of the reverse-takeover transaction referenced in the prior release, and what assets or business is expected to be vended in?
- What drove the NZ$147.1m operating cash outflow in detail — the release references prepayments and other receivables but does not break out working-capital and interest flows.
- What are the terms and maturity of the remaining NZ$930.3m of borrowings, and how do they interact with the NZ$1.0bn cash balance (restricted vs available)?
- Are there discontinued or held-for-sale classifications behind the revenue collapse, or is this a straight run-off of a single continuing segment?
- No dividend, NTA per share, share count, capex or segment information was disclosed, so this briefing cannot assess per-share value, operating unit economics, or the earnings profile of whatever entity emerges post-RTO.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $2.7m | $33.8m | -92.1% ↓ |
| Net profit after tax | −$101.2m | −$215.7m | +53.1% ↑ |
| Net cash inflow from operating activities | −$147.1m | $331.3m | -144.4% ↓ |
| Profit before tax | −$101.2m | −$215.7m | +53.1% ↑ |
| Cash and cash equivalents | $1b | $152.4m | +556.8% ↑ |
| Total assets | $1.1b | $1.5b | -25.2% ↓ |
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| Capex | — | $0m | — |
| Net debt | −$71m | $1.3b | −$1.4b |
| Gross borrowings | $930.3m | $1.4b | −$505.6m |
| HY22 share of FY22 revenue | 86.1% | — | Other half was 13.9% |
| HY22 share of FY22 NPAT | 56.4% | — | Other half was 43.6% |
| Profit from continuing operations | — | −$215.7m | — |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.